Reaction Details Report a problem with these data
Target
Ribosomal protein S6 kinase alpha-6
Ligand
BDBM50578035
Substrate
n/a
Meas. Tech.
ChEMBL_2131827 (CHEMBL4841342)
IC50
29±n/a nM
Citation
 Yuan, Y; Xu, J; Jiang, L; Yu, K; Ge, Y; Li, M; He, H; Niu, Q; Shi, X; Fan, L; Chen, Z; Zhao, Z; Li, S; Xu, Y; Wang, Z; Li, H Discovery, Optimization, and Structure-Activity Relationship Study of Novel and Potent RSK4 Inhibitors as Promising Agents for the Treatment of Esophageal Squamous Cell Carcinoma. J Med Chem 64:13572-13587 (2021) [PubMed]  Article 
Target
Name:
Ribosomal protein S6 kinase alpha-6
Synonyms:
90 kDa ribosomal protein S6 kinase 6 | KS6A6_HUMAN | RPS6KA6 | RPS6KA6(Kin.Dom.1 - N-terminal) | RPS6KA6(Kin.Dom.2 - C-terminal) | RSK-4 | RSK4 | Ribosomal S6 Kinase 4 (RSK-4) | Ribosomal S6 kinase 4 | Ribosomal protein S6 kinase alpha 6 | Ribosomal protein S6 kinase alpha 6 (RSK4) | Ribosomal protein S6 kinase alpha-6 | S6K-alpha 6 | p90-RSK 6 | p90RSK | pp90RSK4
Type:
Serine/threonine-protein kinase
Mol. Mass.:
83868.06
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
745
Sequence:
MLPFAPQDEPWDREMEVFSGGGASSGEVNGLKMVDEPMEEGEADSCHDEGVVKEIPITHHVKEGYEKADPAQFELLKVLGQGSFGKVFLVRKKTGPDAGQLYAMKVLKKASLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDVFTRLSKEVLFTEEDVKFYLAELALALDHLHQLGIVYRDLKPENILLDEIGHIKLTDFGLSKESVDQEKKAYSFCGTVEYMAPEVVNRRGHSQSADWWSYGVLMFEMLTGTLPFQGKDRNETMNMILKAKLGMPQFLSAEAQSLLRMLFKRNPANRLGSEGVEEIKRHLFFANIDWDKLYKREVQPPFKPASGKPDDTFCFDPEFTAKTPKDSPGLPASANAHQLFKGFSFVATSIAEEYKITPITSANVLPIVQINGNAAQFGEVYELKEDIGVGSYSVCKRCIHATTNMEFAVKIIDKSKRDPSEEIEILMRYGQHPNIITLKDVFDDGRYVYLVTDLMKGGELLDRILKQKCFSEREASDILYVISKTVDYLHCQGVVHRDLKPSNILYMDESASADSIRICDFGFAKQLRGENGLLLTPCYTANFVAPEVLMQQGYDAACDIWSLGVLFYTMLAGYTPFANGPNDTPEEILLRIGNGKFSLSGGNWDNISDGAKDLLSHMLHMDPHQRYTAEQILKHSWITHRDQLPNDQPKRNDVSHVVKGAMVATYSALTHKTFQPVLEPVAASSLAQRRSMKKRTSTGL
  
Inhibitor
Name:
BDBM50578035
Synonyms:
CHEMBL4872665
Type:
Small organic molecule
Emp. Form.:
C22H26F2N4O3
Mol. Mass.:
432.4636
SMILES:
CC(C)C1OC(=O)N(C2CCC(C)CC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc12 |(34.85,-41.78,;33.52,-42.56,;32.18,-41.8,;33.54,-44.1,;34.9,-44.88,;34.9,-46.44,;36.24,-47.2,;33.56,-47.21,;33.56,-48.75,;32.24,-49.53,;32.24,-51.06,;33.57,-51.84,;33.57,-53.38,;34.9,-51.06,;34.91,-49.52,;32.21,-46.45,;30.88,-47.21,;29.54,-46.44,;28.21,-47.21,;28.21,-48.75,;29.54,-49.52,;29.55,-51.06,;30.88,-51.83,;28.21,-51.84,;28.21,-53.38,;26.87,-51.06,;25.54,-51.83,;26.88,-49.53,;29.54,-44.9,;30.87,-44.13,;32.21,-44.89,)|
Structure:
Search PDB for entries with ligand similarity: